Comments
AstraZeneca Plc’s Covid-19 vaccine is effective against Delta and Kappa variants, which were first identified in India, the company said on Tuesday, citing a study.
The study by the Oxford University investigated the ability of monoclonal antibodies in blood from recovered people and from those vaccinated to neutralise the Delta and Kappa variants, the statement said. Last week, an analysis by Public Health England (PHE)showed that vaccines made by Pfizer Inc and AstraZeneca offer high protection of more than 90 per cent against hospitalisation from the Delta variant.
Working with AstraZeneca, SII, Indian govt to restart Covid-19 vaccine shipments: WHO Official
The latest Oxford study results are built on the recent analysis by PHE, the company said.
AstraZeneca says antibody treatment failed in preventing Covid-19 in exposed patients
The Delta variant is becoming the globally dominant version of the disease, the World Health Organization’s chief scientist said on Friday.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.